EPA & DHA Market Size, Share & Industry Analysis, By Type (Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)), By Source (Algae, Fish, Krill, Others), By Application (Dietary Supplements, Functional Food & Beverages, Infant Formulae, Pharmaceuticals, Others) and Regional Forecast, 2023-2030

The global EPA & DHA market is expected to witness a considerable rise during the forecast years, due to rising awareness regarding the health benefits associated with the consumption of EPA (Eicosapentaenoic acid) & DHA (Docosahexaenoic acid), such as lowering the risk of heart diseases, reduced inflammation, supporting muscle and brain health, and others. Growing demand for EPA & DHA from various application sectors is further projected to intensify the growth of global Eicosapentaenoic acid & Docosahexaenoic acid market in the upcoming years.

Key companies operating in the global EPA & DHA market are focusing on merger & acquisition activities, along with expanding their product portfolio and launching new products to maintain their significance in the world EPA and DHA market. BASF SE, Organic Technologies, and Archer Daniels Midland Company are some of the key companies operating in the global EPA & DHA market.

To gain extensive insights into the market, Request for Customization

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are crucial omega-3 fatty acids, also termed as heath-benefitting dietary fats, that have wide applications. The demand for highly purified EPA & DHA is augmenting due to increase in demand for high-quality EPA & DHA ingredients for the production of various health products.

Growing incidence of chronic diseases is encouraging consumers to include dietary supplements and other health-boosting products in their daily routine, which in turn is anticipated to drive the growth of EPA & DHA market during the foreseeable years. Increasing demand for EPA & DHA from clinical nutrition industry, infant food manufacturers, and others are expected to impact the global EPA & DHA market crucially during the forecast years. Furthermore, increasing number of market players, coupled with increasing awareness regarding the significance of EPA & DHA in weight management is projected to positively influence the EPA & DHA market growth during the foreseeable years. However, mild side-effects of consumption of EPA & DHA among some individuals, coupled with fluctuations in raw material prices is anticipated to hinder the growth of the market during the forecast years.

Key Players Covered

Some of the major companies that are present in the global EPA & DHA market are Archer Daniels Midland Company, Koninklijke DSM N.V., BASF SE, Croda International Plc., Corbion N.V., Golden Omega S.A., Novasep Holding SAS, Arctic Nutrition AG, Organic Technologies, and Pelagia AS among the other players operating in the global EPA & DHA market.

Segmentation

On the basis of source, the global EPA & DHA market has been segmented into algae, fish, krill, and others. Fish segment dominates the market and is expected to retain its dominance throughout the foreseeable years, owing to higher EPA and DHA content present in oily fish. Easy extraction of EPA & DHA from fish is another prominent reason which is projected to aid the growth of the segment throughout the forecast years. Cost efficiency of DHA & EPA extracted from fish oil is another significant propeller for the growth of the fish segment.

On the basis of application, the global EPA & DHA market has been segmented into dietary supplements, functional food & beverages, infant formulae, pharmaceuticals, and others. Among these, the major demand for EPA and DHA is expected to come from dietary supplements segment, the demand of which is fostering across developed as well as developing markets.

Regional Analysis

Asia Pacific and North America is expected to hold the major market share in the global EPA & DHA market during the forecast years, owing to high health awareness among people based in developed countries of North America such as U.S. and Canada, coupled with escalating health consciousness among consumer based in developing economies of Asia, such as China and India. High birth rate in developing economies of Asia Pacific is expected to fuel the demand for DHA & EPA-based ingredients that have major applications across infant formulae. Furthermore, significant growth in the middle-class population of India and China, coupled with increasing per capita income of people in the aforementioned countries is projected to aid the growth of the global EPA & DHA market during the forthcoming years.

Key Industry Developments

• In August 2018, Archer Daniels Midland Company announced the launch of Onavita algal DHA powder and expanded its line of omega-3 product solutions. The product claims to be efficient in utilization across wide variety fortified food products and dietary supplements.


• In September 2017, Evonik Industries, a Germany-based specialty chemical company launched AvailOm, a high concentration omega-3 lysine complex that contain minimum of 45% EPA and DHA by weight